Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies
Completed · Not applicable
Conditions studied: Acute Disease, Myelodysplastic Syndromes, Leukemia, Myeloid, Chronic, Myeloproliferative Disorders, Blood and Marrow Transplant (BMT), Myelodysplastic Syndromes (MDS), Leukemia
In brief
The purpose of this study is to determine the tolerability and efficacy in treating patients aged 51-60 with acute leukemia and in treating myelodysplastic syndromes (MDS) or myeloproliferative disorders (MPD).
Key facts
- Study ID
- NCT00186342
- Run by
- Stanford University
- People needed
- 120
- Starts
- 1992-09-01
- Expected to finish
- 2009-01-01
- Last updated by the study team
- 2012-12-17
Who can join
Age: 51 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.